Several mutations in genes encoding the low-density lipoprotein receptor (LDLR), apolipoprotein B (ApoB), or Protein convertase subtilisin/kexin type 9 (PCSK9) account for the majority of FH cases [16, 17]. This evidence concerns the gene LDLR and familial hyperaldosteronism.